文献速递神经肿瘤

术后残留无功能垂体腺瘤:辅助放疗与单纯观察的比较

Adjuvant Radiation Therapy Compared with Observation Alone for Postoperative Residual Nonfunctional Pituitary Adenomas.
PubMed 文献 · World Neurosurg · 2019-05-17

该回顾性研究纳入2008年1月至2012年4月接受手术的90例无功能垂体腺瘤患者,比较术后残留肿瘤观察与术后放疗的预后及长期并发症,结果显示放疗组3年以上无进展生存比例更高,对肿瘤≥3 cm或位于海绵窦者获益显著,放疗后最常见并发症为垂体功能减退。

要点

  • 术后残留无功能垂体腺瘤放疗组3年以上无进展生存比例高于观察组
  • 肿瘤≥3 cm或位于海绵窦者从术后放疗中获益显著
  • 放疗后最常见并发症为垂体功能减退,长期并发症较轻

核心结论

  • 肿瘤切除后立即放疗是残留或进展性无功能垂体腺瘤有效且相对安全的治疗选择。
  • 放疗长期并发症较轻。

研究设计与样本

  • 回顾性分析2008年1月至2012年4月接受手术的无功能垂体腺瘤患者90例。
  • 按肿瘤大小、位置和病理染色对残留肿瘤分类,比较观察组与术后放疗组的进展及3年、5年无进展生存。
  • 术后放疗在末次手术后1年内进行。

主要发现

  • 接受术后放疗的患者中无进展生存≥3年的比例高于未接受放疗者。
  • 术后放疗对肿瘤大小≥3 cm或肿瘤位于海绵窦的患者显著有益。
  • 放疗后最常见并发症为垂体功能减退,少数病例出现第三颅神经麻痹,但与放疗无显著关系。

关键数值与推荐

  • 肿瘤进展定义为体积进展≥15%,伴或不伴临床症状。
  • 术后放疗在末次手术后1年内进行。

临床怎么用

  • 对术后残留无功能垂体腺瘤可考虑早期辅助放疗,尤其肿瘤≥3 cm或位于海绵窦者。
  • 放疗后需关注垂体功能减退等长期并发症。

局限性

  • 回顾性研究设计。
  • 样本量90例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The management of residual nonfunctional pituitary tumors after surgical resection remains controversial. In this study, we compared the prognosis of postoperative radiation therapy and observation only in patients with residual nonfunctional pituitary adenoma and reviewed the long-term complications after radiation therapy. METHODS: We retrospectively analyzed 90 patients who underwent surgery for nonfunctional pituitary adenomas from January 2008 to April 2012. Residual tumors were classified by size, location, and pathologic staining. Tumor progression was defined as volume progression ≥15% with or without clinical symptoms. Postoperative radiation therapy was performed <1 year after the last surgery. We compared the progression and 3-year and 5-year progression-free survival between the observation group and postoperative radiation therapy group. Postradiation complications including hypopituitarism, diabetes insipidus, deterioration in visual field or acuity, cranial nerve palsy, and hydrocephalus were also analyzed. RESULTS: More of the patients who received postoperative radiation therapy had a tumor progression-free survival of ≥3 years than did those who did not receive postoperative radiation therapy. Postoperative radiation therapy was significantly beneficial for the patients with a tumor size ≥3 cm or with tumors in the cavernous sinus. The most frequent complication after radiation therapy was hypopituitarism and a few cases had third cranial nerve palsy; however, there were no significant relationships with radiation therapy. CONCLUSIONS: In this study, immediate radiation therapy after tumor resection was an effective and relatively safe treatment for residual or progressive nonfunctional pituitary adenomas. Moreover, the long-term complications of radiation therapy were mild.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Deng WC, Yan JL, Chuang CC, et al. Adjuvant Radiation Therapy Compared with Observation Alone for Postoperative Residual Nonfunctional Pituitary Adenomas. World Neurosurg. 2019. PMID: 31103758. doi:10.1016/j.wneu.2019.05.066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。